← All trials
NCT06732531
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 3, 2022
- Primary completion
- Dec 19, 2023
- Completion date
- Sep 30, 2025
- First posted
- Dec 13, 2024
- Last posted
- Dec 13, 2024
- Enrollment
- 48
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Zhuhai Beihai Biotech Co., LtdLead sponsor
- Zhuhai Beihai Biotech Co., LtdOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.